As a science policy forum the Ludwig Boltzmann Gesellschaft (LBG) asked for the first time researchers, policy makers and journalists to get together for the "Weinherbst" on the 20th Floor of the new Raiffeisen building in the heart of Vienna. The impressive panorama presented the backdrop for an inspiring meeting of science and research community. President of LBG Josef Pröll and science and research minister Univ.-Prof. Dr. Karlheinz Töchterle welcomed the numerous guests.
Andreas Sommer, head of genomics at the Campus Support Facility (CSF), gave an introduction to the tecnological advances in modern genetics and highlighted the capabilities and options available to external researchers. At a subseqent get together members of the LBI-CR explored access to the facilities and discussed differernt technological options. All in all the Seminar provided a stimulating reminder to include modern genomics technologies into the research approaches of the LBI-CR.
For the national science day "Lange Nacht der Forschung" the LBI-CR will present its station "Where does cancer come from?".
We are all looking forward to interested visitors and surprising questions.
The research team of the LBI-CR
The LBG management met with the heads of the various LBI and LBC at Reichenau an der Rax. The meeting provides a forum for the management staff to get informed about future developments and challenges research isntitutions are facing in Austria.
"Loss of Androgen Receptor Expression Promotes Prostate Cancer Stem-Like Cell Phenotype through STAT3 signaling."
The Aflac Cancer and Blood Disorders Center of Emory University is one of the leading pediatric cancer, hematology, and blood and marrow transplant (BMT) programs in the US. As such it provides advanced diagnostic and clinical care, as well as innovative treatment and research options to children, adolescents and young adults.
Dr. Richard Moriggl gave a presentation at the Aflac Leukemia/Lymphoma group meeting entitled:
"Gene dosage of STAT5 alters lymphocyte development and cancer progression with a key role for the CD8 T cell lineage"